Copyright
©The Author(s) 2016.
World J Gastroenterol. Sep 14, 2016; 22(34): 7727-7734
Published online Sep 14, 2016. doi: 10.3748/wjg.v22.i34.7727
Published online Sep 14, 2016. doi: 10.3748/wjg.v22.i34.7727
Risk factors | OR/HR (95%CI) | P value |
Small bowel surgery[13] | OR = 3.7 (1.5-9.3) | 0.005 |
Hypertension[13] | OR = 3.5 (1.5-8.1) | 0.004 |
Obesity[13] | OR = 2.1 (1.05-4.0) | 0.035 |
Steroid use[13] | OR = 3.7 (1.5-9.3) | 0.005 |
Active disease[22] | HR = 1.58 (1.07-2.33) | 0.020 |
Duration of IBD[22] | HR = 1.12 (1.03-1.23) | 0.010 |
Prior IBD surgery[22] | HR = 1.34 (1.04-1.74) | 0.020 |
Anti-TNFα use[22] | HR = 1.69 (0.99-2.90) | 0.056 (Trend to significance) |
- Citation: Chao CY, Battat R, Al Khoury A, Restellini S, Sebastiani G, Bessissow T. Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: A review article. World J Gastroenterol 2016; 22(34): 7727-7734
- URL: https://www.wjgnet.com/1007-9327/full/v22/i34/7727.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i34.7727